Funding is now sorted and we don't have going concern issues as there is $1 mil in the Bank and 2.4 mil has been underwritten. So funding which held the SP back is not an issue.
I wonder what the announcement of the following results will do to the SP.
Results due in Jan 2018
DX1-nanoparticle delivery – breast cancer animal data
DX1-nanoparticle tumor localization – breast cancer
Results due in Feb 2018
DX1 ability to cross the blood brain barrier – brain cancer
These results are very close and management surely know what they will look like.
Brainy
Ann: $2.4 Million Fully Underwritten Rights Issue, page-5
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $7.201M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $564 | 161.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 29348732 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 26555626 | 17 |
View Market Depth
| Last trade - 12.59pm 18/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |